ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 82 filers reported holding ADICET BIO INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,109,184 | -46.4% | 2,269,478 | -5.0% | 0.00% | – |
Q2 2023 | $5,802,140 | -60.3% | 2,387,712 | -5.9% | 0.00% | – |
Q1 2023 | $14,611,981 | -35.8% | 2,536,802 | -0.3% | 0.00% | -100.0% |
Q4 2022 | $22,757,825 | -24.1% | 2,545,618 | +20.7% | 0.00% | 0.0% |
Q3 2022 | $30,003,000 | +11.1% | 2,109,787 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $26,997,000 | -16.5% | 1,849,082 | +14.3% | 0.00% | 0.0% |
Q1 2022 | $32,314,000 | +27.2% | 1,618,107 | +11.4% | 0.00% | 0.0% |
Q4 2021 | $25,403,000 | +159.5% | 1,452,452 | +16.3% | 0.00% | – |
Q3 2021 | $9,788,000 | -23.0% | 1,248,519 | +1.1% | 0.00% | – |
Q2 2021 | $12,711,000 | +98.5% | 1,235,313 | +152.3% | 0.00% | – |
Q1 2021 | $6,404,000 | +66.1% | 489,628 | +78.4% | 0.00% | – |
Q4 2020 | $3,856,000 | +141.9% | 274,462 | +104.7% | 0.00% | – |
Q3 2020 | $1,594,000 | – | 134,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |